Sponsor:
Kennesaw State University
Code:
NCT07221279
Conditions
Dyslipidemia
Insulin Resistance Syndrome
Hypertension
Inflammation Chronic
Obesity & Overweight
Eligibility Criteria
Sex: All
Age: 20+
Healthy Volunteers: Accepted
Interventions
Step counts for predictable changes in body weight/compositon and cardiometabolic risk
Brief summary:
Conditions
Dyslipidemia
Insulin Resistance Syndrome
Hypertension
Inflammation Chronic
Obesity & Overweight
Study ID
NCT07221279
Start date
Jan 13, 2025
Status verified date
Sep, 2025
Completion date
Aug 31, 2027
Anticipated
Primary completion date
Aug 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 20+
Healthy Volunteers: Accepted
Enrollment
200 participants
Anticipated
Intervention Model
Single group
Primary purpose
Prevention
Arms
experimental: Regular accumulation of step count targets to achieve predictable weight loss
Interventions
Step counts for predictable changes in body weight/compositon and cardiometabolic risk
Primary outcome measure
Central contacts
Brian Kliszczewicz, PhD
bkliszcz@kennesaw.eduLocations
Kennesaw State Universityh
Recruiting
Kennesaw, Georgia, United States, 30144
Contacts
Sponsor
Kennesaw State University
Last update posted
Oct 27, 2025
Last verified
Sep, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Kennesaw State University on 2025-10-27.